Skip to main content

Table 2 Baseline Lesion Characteristics

From: Long-term clinical effectiveness of a drug-coated balloon for in-stent restenosis in Femoropopliteal lesions

Variables

Overall population

Matched population

PCB (n = 32)

Non-PCB (n = 74)

p

PCB (n = 25)

Non-PCB (n = 25)

p

Target lesion

 Superficial femoral artery

32 (100.0)

74 (100.0)

1.000

25 (100.0)

25 (100.0)

1.000

 Involving popliteal artery

4 (12.5)

19 (25.7)

0.199

4 (16.0)

7 (28.0)

0.496

Reference vessel diameter, %

5.65 ± 0.40

5.54 ± 0.47

0.282

5.61 ± 0.37

5.50 ± 0.49

0.367

Lesion length of native disease, %

223.4 ± 68.4

200.9 ± 81.4

0.173

222.0 ± 73.5

209.6 ± 78.4

0.567

Total occlusion of native disease, %

27 (84.4)

55 (74.3)

0.318

20 (80.0)

21 (84.0)

1.000

TASC II classification of native disease

  

0.177

  

0.217

 A/B

4 (12.5)

21 (18.4)

 

3 (12.0)

6 (24.0)

 

 C

6 (18.8)

15 (20.3)

 

5 (20.0)

5 (20.0)

 

 D

22 (68.7)

38 (51.3)

 

17 (68.0)

14 (56.0)

 

PACSS classification of native disease

  

0.937

  

0.702

 0–3

27 (84.4)

64 (86.5)

 

20 (80.0)

22 (88.0)

 

 4

5 (15.6)

10 (13.5)

 

5 (20.0)

3 (12.0)

 

Types of ISR-related stents

  

1.000

  

1.000

 Bare-nitinol stent

30 (93.7)

69 (93.2)

 

24 (96.0)

25 (100.0)

 

  SMART™

10 (31.3)

21 (28.4)

 

7 (28.0)

9 (36.0)

 

  Luminexx™

15 (46.9)

33 (44.6)

 

14 (56.0)

13 (52.0)

 

  Zilver 518™

1 (3.1)

3 (4.1)

 

1 (4.0)

0 (0.0)

 

  Misago™

4 (12.5)

11 (14.9)

 

2 (8.0)

2 (8.0)

 

  LIFE STENT™

0 (0.0)

1 (1.4)

 

0 (0.0)

1 (4.0)

 

 Drug-coated stent (Zilver PTX™)

2 (6.3)

5 (6.8)

 

1 (4.0)

0 (0.0)

 

ISR pattern*

  

< 0.001

  

0.581

 Focal (≤50 mm)

2 (6.3)

25 (33.8)

 

2 (8.0)

2 (8.0)

 

 Diffuse (> 50 mm)

24 (75.0)

22 (29.7)

 

19 (76.0)

16 (64.0)

 

 Occlusion

6 (18.7)

27 (36.5)

 

4 (16.0)

7 (28.0)

 

ISR length*

120.3 ± 59.3

131.1 ± 95.6

0.555

126.0 ± 57.4

134.4 ± 71.4

0.649

Distal run-off vessel

  

0.378

  

1.000

 2/3

23 (71.9)

45 (60.8)

 

17 (68.0)

18 (72.0)

 

 0/1

9 (28.1)

29 (39.2)

 

8 (32.0)

7 (28.0)

 

Stent fracture classification

  

0.582

  

1.000

 0/1/2

30 (93.7)

72 (97.3)

 

22 (92.0)

24 (96.0)

 

  ≥ 3

2 (6.3)

2 (2.7)

 

2 (8.0)

1 (4.0)

 
  1. Categorical variables are expressed as number and percentage. Continuous variables are indicated as mean ± SD
  2. ISR indicates in-stent restenosis, PACSS Proposed Peripheral Arterial Calcium Scoring System, PCB paclitaxel-coated balloon, TASC Trans-Atlantic Inter-Society Consensus
  3. *Variables included in the multivariable analysis to estimate propensity score